RaySearch develops proton therapy system for Uppsala University Hospital

RaySearch develops proton therapy system for Uppsala University Hospital

RaySearch Laboratories AB has signed a consulting agreement with the Uppsala
University Hospital in Sweden, covering the development of a new treatment
planning system for proton radiation therapy delivered at the The Svedberg
Laboratory in Uppsala. The system is planned be used clinically during 2008 and
will replace an outdated system for all patient treatments. The University
Hospital treats more than 100 cancer patients annually with proton therapy.

“To capitalize on the advantages with proton therapy, which is more precise than
conventional radiation therapy, a reliable and accurate dose calculation is of
extra importance. This will be provided by this system from RaySearch,” says Ulf
Isacsson, responsible for radiation therapy at the Hospital Physics department
of the University Hospital. 

“We know that RaySearch has a fast development process in which we can be
actively involved so we will get a modern user-friendly system that is fully
integrated into our existing routines for radiation therapy,” concludes Ulf
Isacsson.

Johan Löf, President of RaySearch, adds: “We are extremely proud to have the
University Hospital as a partner. They have exceptionally long clinical
experience and were first in the world to treat cancer tumors with protons. The
agreement has no direct financial impact on RaySearch, but it is of high
strategic importance that our proton system will now be used clinically for the
first time.”

Proton therapy is one of RaySearch's prioritized development areas and the
company demonstrated its solutions earlier this year at the international PTCOG
(Particle Therapy Cooperative Group) meeting, which was held in Jacksonville,
Florida.

FOR FURTHER INFORMATION, CONTACT:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com


ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch's
products are sold through license agreements with leading partners such as
Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have
been released to date and RaySearch's software is used at over 1,300 clinics in
more than 30 countries. In addition, existing license agreements cover more than
15 other products that are scheduled to be launched in the coming years.
RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in
Stockholm and the company is listed in the SmallCap segment on the OMX Nordic
Exchange Stockholm. 

For more information about RaySearch, visit www.raysearchlabs.com.